Abstract
Background Long-acting injectable antiretroviral therapy offers an alternative to daily oral HIV treatment, potentially improving adherence and reducing stigma. While its adoption has been successful in some settings, little is known about its acceptability among people living with HIV in Kenya. This study evaluates the acceptability, barriers, and facilitators of long-acting injectable antiretroviral therapy among people living with HIV in Nairobi, Kenya.
Methods We conducted a mixed-methods study involving 356 people living with HIV receiving care at Kenyatta National Hospital and Aga Khan University Hospital. Quantitative data were collected through structured surveys, while qualitative insights were obtained from three focus group discussions. Descriptive and inferential statistical analyses were performed on survey data, and thematic analysis was applied to focus group discussions transcripts.
Results Overall, 72.2% of participants expressed willingness to switch to long-acting injectable antiretroviral therapy Interest in long-acting injectable antiretroviral therapy was significantly associated with prior knowledge (93.9% vs 80.2%, p < 0.001) and more likely among women ((93.5% vs. 83.9%, p = 0.009). Key facilitators included the opportunity to stop taking daily pills (71.3%), improved adherence (50.3%) and reduced daily focus on HIV (44.7%). The most frequently cited barriers were fear of side effects (69.7%), needle phobia (32.3%), and distrust in new treatments (20.2%). focus group discussions revealed interest about long-acting injectable antiretroviral therapy’s potential to reduce stigma and improve adherence, but also concerns about side effects, access, and the need for robust support systems.
Conclusion People living with HIV in the participating hospitals in Nairobi showed strong interest in long-acting injectable antiretroviral therapy, driven by its potential to improve adherence and reduce stigma. However, concerns about side effects, injections, and access must be addressed. Targeted education, provider training, and healthcare support are crucial for successful implementation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Kenyatta National Hospital-University of Nairobi Ethics Research Committee: Approval number P816/10/2023 Aga Khan University, Kenya ISERC Approval no: 2023/ISERC-50 Written consent was obtained from all participants
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos